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Abstract Hypothermia-induced reduction of metabolic rate
is accompanied by depression of both glomerular perfusion
and filtration. The present study investigated whether these
changes are linked to changes in renal autoregulation and
nitric oxide (NO) signalling. During hypothermia, renal blood
flow (RBF) and glomerular filtration rate (GFR) were reduced
and urine production was increased, and this was linked with
reduced plasma cGMP levels and increased renal vascular
resistance. Although stimulation of NO production decreased
vascular resistance, blood pressure and urine flow, intravenous
infusion of the NO precursor L-arginine or the NO donor
sodium nitroprusside did not alter RBF or GFR. In contrast,
inhibition of NO synthesis by Nw-nitro-L-arginine led to a
further decline in both parameters. Functional renal autoregu-
lation was apparent at both temperatures. Below the
autoregulatory range, RBF in both cases increased in propor-
tion to the perfusion ±pressure, although, the slope of the first
ascending limb of the pressure-flow relationship was lower
during hypothermia. The main difference was rather that the
curves obtained during hypothermia levelled off already at a
RBF of 3.9 ± 0.3 mL/min then remained stable throughout the
autoregulatory pressure range, compared to 7.6 ± 0.3 mL/min
during normothermia. This was found to be due to a threefold
increase in, primarily, the afferent arteriolar resistance from
2.6 to 7.5 mmHg min mL−1. Infusion of sodium nitroprusside
did not significantly affect RBF during hypothermia, although
a small increase at pressures below the autoregulatory range
was observed. In conclusion, cold-induced rise in renal vas-
cular resistance results from afferent arteriolar vasoconstric-
tion by the autoregulatory mechanism, setting RBF and GFR
in proportion to the metabolic rate, which cannot be explained
by reduced NO production alone.
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Introduction
In our previous studies [5, 6], moderate hypothermia at 28 °C
(HT) was found to be accompanied by an approximately 50%
reduction of total renal blood flow (RBF), and glomerular filtra-
tion rate (GFR) compared with normothermia (NT) at 37.5 °C.
Since the blood pressure remained largely unchanged, it was
calculated that the renal vascular resistance increased twofold,
of which 75% was attributed to active vasoconstriction of, pri-
marily, the afferent arteriole.
In search for the factor(s) underlying this pronounced vaso-
constriction, an activation of the sympathetic nervous system, our
major cold defence system [17], was an unlikely candidate since
direct recordings showed that efferent renal sympathetic nerve
activity was decreased [6, 30, 33]. Likewise, surgical renal de-
nervation andα1-adrenoceptor blockadewere found not to lessen
the cold-induced vasoconstriction [6]. A study using micropunc-
ture technique showed that both single nephron GFR, and prox-
imal and distal tubular fluid flow decreased by approximately
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50% during HT [5]. The diuresis, however, increased three- to
sixfold that could be attributed to a vasopressin-dependent de-
crease in water reabsorption at the distal tubule and collecting
duct [7].
In the present study, we addressed the question of whether
the increased arteriolar tone was due (1) to cold-induced inhi-
bition of nitric oxide (NO) production, or (2) to a resetting of
the renal autoregulatory mechanism. Concerning the first pos-
sibility, it is firmly established that NO plays an important role
in the control of vasomotor tone in the renal vascular bed [10,
31]: Inhibition of NO formation by NO synthase inhibitors has
been found to increase renal vascular resistance and reduce
RBF not only in pressor dosages [2, 25], but also in dosages
not affecting the systemic blood pressure [10, 14, 24].
Conversely, infusion of the NO precursor L-arginine and the
NO donor sodium nitroprusside (SNP) has been found to lessen
renal vasoconstriction [22, 23]. The second alternative consid-
ered was that the cold-induced increase in vascular resistance
may be due to a metabolism-dependent resetting of the mech-
anism that determines the blood flow within the autoregulatory
range. This might be part of the tubuloglomerular feedback
mechanism (TGF) [37], where an increased tubular fluid load,
sensed by themacula densa cells at the end of the thick ascend-
ing limb (TAL) of Henle’s loop leads to constriction of the
afferent arteriole, which then decreases glomerular perfusion
and filtration, and vice versa. In other words, the tubular fluid
flow determines RBF. The key point in this consideration
would be that the sensitivity of the mechanism may vary from
one condition to another [31]; as an example, volume expan-
sion has been found to reduce the TGF sensitivity to allow for a
relatively high GFR, whereas dehydration will result in in-
creased sensitivity and hence in a decrease in GFR. Further, it
should be noted that according to several previous publications
[8, 9, 36, 38], inhibition of NO will increase TGF sensitivity.
Therefore, the cold-induced decrease in blood flow and GFR
would seem not to be dependent on the TGF.
In the present study, two series of experiments were per-
formed. The aim of the first series was to investigate the hy-
pothesis that the cold-induced vasoconstriction was due to
impairment of the formation and/or action of NO. This was
examined by investigating the effects of intravenous infusion
of the NO precursor L-arginine, and of the NO donor SNP, as
well as by inhibition of NO synthesis by Nw-nitro-L-arginine
(L-NNA). In a second series, renal autoregulation was studied
during NT and HT both before and after intrarenal infusion of
SNP. Finally, in a third series, the regulation of NO homeosta-
sis and oxidative stress was investigated during NT and HT.
Materials and methods
The studies were performed on 50 male Sprague-
Daw l ey r a t s (Mö l l e g a a r d s B r e ed i ng Cen t e r ,
Copenhagen, Denmark) weighing 340 ± 14 g
(mean ± SE). The animals had free access to rodent
chow (R36, EWOS, Södertälje, Sweden) and tap water,
and housed in rooms at 22 °C with a 12/12 day-night
cycle until the experiments began. All animal proce-
dures in this study were in strict adherence to the
Guide for the Care and Use of Laboratory Animals as
adopted by the U.S. National Institutes of Health and
were approved by the Regional Animal Care and Use
Committee of Uppsala or Stockholm in Sweden.
The r a t s we r e an a e s t h e t i s e d w i t h I n a c t i n®
(thiobutabarbital, Byk-Gulden, Konstanz, Germany), admin-
istered intraperitoneally in a dose of 120 mg per kg. After
tracheostomy, the rat was placed on a servo-controlled heating
pad which kept the body temperature stable at 37.5 °C under
control conditions and at 28 °C during HT.
Catheters were inserted into the right femoral artery
and vein; the arterial catheter to be used for measure-
ments of blood pressure and withdrawal of blood sam-
ples, and the venous catheter for infusion of isotonic
saline at a rate of 5 mL kg−1 h−1 to cover fluid losses.
The left kidney was exposed through a flank incision,
suspended in a Lucite cup and covered with heated mineral
oil to prevent drying. The urine from the left kidney was
sampled via a catheter inserted into the proximal ureter. In
series II, urine was also collected from the right kidney via a
supra-pubic catheter inserted into the bladder. In this series,
the autoregulation of the RBF was investigated, hence renal
perfusion pressure was set by placing an adjustable clamp
around the abdominal aorta proximal to the left renal artery.
In series III, blood and urine samples were collected, as de-
scribed above, during the NT and HT periods, and kidneys
were excised at the end of the protocol. All tissue samples
were instantly frozen using dry ice and stored (−80 °C) for
later analyses (see below).
Analysis and calculations GFR was determined as the clear-
ance of 3H–inulin (NEN, Boston, MA, USA). For this pur-
pose, 2.5 mCi of this tracer was added to each millilitre of the
saline that was infused to cover fluid losses. The radioactivity
of 3H–inulin in collected plasma and urine samples were mea-
sured by liquid scintillation technique.
In series I, the RBF was analysed by Ficks principle by
dividing the urinary excretion of inulin with its arteriovenous
concentration difference. In order to sample renal venous
blood, the renal vein was catheterised with a silicon tube with
an outer diameter of 1 mm. This flexible tubing was intro-
duced via a hole in the vein first made by a steel cannula.
Ten minutes after puncture, the cannula was withdrawn with-
out any blood loss and replaced with the silicon catheter [1].
In series II, RBF was measured continuously with an ultra-
sonic flow probe (1RB/T206, Transonic Systems Inc., Ithaca,
NY, USA) that was placed around the left renal vein. From
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these data, the renal vascular resistance under the various con-
ditions was calculated: Experimental data were utilised to cal-
culate vascular conductance (C) since the error in the determi-
nation of RBF is generally larger than that of pressures. An
error in the very low blood flows recorded at lesser pressures
will result in a very large error in the renal vascular resistance
(RVR), ΔP/ΔRBF. In the determination of C, on the other
hand, the percentage error in C will be the same as that in
blood flow. C was calculated by dividing the RBF by the renal
perfusion pressure. The latter was obtained as mean arterial
pressure (MAP) minus critical closing pressure. RVR was
then assessed as the reciprocal of this conductance
(RVR = 1/C). Continued discussion will be based on resis-
tance in that it is easy to comprehend and because resistances
can be added in order to obtain the total resistance.
Critical closing pressure A certain perfusion pressure is
needed to open up and commence blood flow through
an organ, e.g. the renal vasculature. The renal interstitial
pressure may not be, as for other organs, an equivalent
to the intraabdominal pressure (IAP) [21] below which
organ perfusion ceases to occur. The abdominal perfu-
sion pressure is considered the difference between the
mean ar ter ia l blood pressure (MAP) and IAP.
Concerning the kidneys, however, it has previously been
shown that the pressure in the small intrarenal veins is
about 10 mmHg higher than in the extrarenal veins
[20]. Thus, best estimate for the closing pressure was
used, i.e. the point of intersection by the ascending limb
of the autoregulatory curve of the x-axis. These curves
crossed at 10 mmHg (Figs. 1 and 2a).
Experimental protocol
Series I: intravenous infusion of L-arginine, SNP and L-NNA
The experiments began about 1 h after completion of surgery,
when the rat was considered to be in steady state. All the
experiments comprised three 20-min periods.
Period 1 was the control period during which the rat body
temperature was set at its normal value of 37.5 °C. After the
first period, cooling was commenced by turning the servo-
controlled heating pad to 28 °C and covering the animal with
medical rubber gloves containing crushed ice. When the body
temperature had reached 28 °C, the ice was removed and the
temperature was maintained by the heating pad. The time
taken to reach 28 °C ranged from 60 to 100 min.
Period 2 was the hypothermic control period that started
about 20 min after the body temperature had become stable.
Period 3 was the hypothermic experimental period, during
which either L-arginine (Sigma Labkemi, Stockholm, Sweden),
SNP (Nipride, Roche, Basel Schweiz) or L-NNA (Nw-nitro-L-
arginine, Sigma Labkemi) was administered intravenously. L-
arginine was given at a rate of 17 mg kg−1 min−1 preceded by
a bolus injection of 100 mg kg−1. SNP was given in a dose of 2–
7 mg kg−1 min−1. The dose was set such that MAP did not fall
below 95 mmHg. L-NNAwas infused in 10 min in a single dose
of 20 mg/kg.
A control group of experiments was performed with the
same protocol as above but at NT during all three periods.
Series II: autoregulation of RBF before and during infusion
of SNP
The effect of NO on renal autoregulation was studied by in-
fusing SNP at a dose of 1–4 mg/kg per minute into the left
renal artery through a 200-μm polyethylene catheter inserted
via a lumbar artery and then advanced with the tip located just
inside the renal artery, a technique that enables a very good
mixing of the infused substances. In order to prevent coagu-
lation in the catheter before the administration of SNP, saline
was continuously infused at a rate of 3 mL/min.
Series III: NO homeostasis and oxidative stress
After completing the surgery, a recovery period of
25 min was allowed before starting the experimental
protocols. Urine and blood samples were collected after
a period with NT (30 min), which was followed by
induction of HT as described above. Urine and blood




























Fig. 1 Autoregulation: Relation between mean arterial blood pressure
(i.e. perfusion pressure) and RBF in one experiment during NT (upper
curves, diamonds), and HTat 28 °C (lower curves, squares) before (filled
diamonds/squares) and during intrarenal infusion of sodium nitroprusside
(open diamonds/squares)
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HT (30 min), and the kidneys were removed and frozen.
A time-matched control group was used where the first
NT period was followed by a second NT period.
Obtained blood samples were immediately centrifuged
at +4 °C (5 min; 4700 g) and the plasma was stored
at −80 °C until analyses.
Cyclic guanosine monophosphate (cGMP) Plasma content
of cGMP was analysed using Direct Biotrak EIA kit
(RPN226, GE Healthcare Life Sciences, Uppsala, Sweden),
according to manufacturer’s instructions including the acety-
lation protocol. An inhibitor of cAMP/cGMP phosphodiester-
ases (IBMX) was added to plasma samples (final conc.
10 μM) before freezing and later processing to prevent deg-
radation of cGMP [18].
Nitrate and nitrite Urine samples were diluted (1:20) in
Carrier solution containing 10% methanol before being
analysed. Plasma samples were extracted using high-
performance liquid chromatography (HPLC)-grade methanol
(Chromasolv, Sigma-Aldrich), and the frozen kidney samples
were cut and homogenised as described previously [8]. A
HPLC system dedicated to assessment of nitrite and nitrate
(ENO-20; EiCom, Japan) and attached to an auto-sampler
(840, EiCom, Kyoto, Japan) was used. Detailed method de-
scription was recently published [28].
NADPH oxidase activity Chemiluminescence technique
was used to determine NADPH stimulated superoxide
formation in the kidney [18]. In brief, frozen kidney
samples were homogenised in PBS with zirconium ox-
ide beads (0.5 mm) in the bullet blender. The superna-
tant was collected after centrifugation at 4 °C for
20 min at 2000 g. Supernatant containing 500 μg of
protein was added into a test tube with 1 ml PBS and
5 μmol/L lucigenin and the reaction was started by the
addition of 100 μmol/L NADPH. The chemilumines-
cence signal was calculated over a period of 3 min
and corrected by tissue amount.
Statistics All data are given as mean ± SE, and a p
value less than 0.05 was considered to be a statistically
significant difference. Two-way analysis of variance
(ANOVA) with repeated measures was performed, and
for comparison between groups in the same period,
Tukey’s post-test was applied. For single comparison
of data from the left and right kidney, paired t test
was used. For the analyses of NO homeostasis (plasma,
kidney, urine) and NADPH oxidase activity (kidney),
two-way ANOVA with repeated measures and Sidak’s
tes t (mul t ip le compar isons) or non-parametr ic




























































Fig. 2 Autoregulation: Relation between mean arterial blood pressure
(i.e. perfusion pressure) and RBF (a) and renal vascular resistance (b)
in eight experiments during NT, and HT at 28 °C (lower curves in a;
upper curves in b). During HT the autoregulatory curve is shown both
before (solid line) and during intrarenal infusion of sodium nitroprusside
(dashed line). Values are shown as mean ± SE
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Results
Series I: intravenous infusion of L-arginine, SNP
and L-NNA
During hypothermia at 28 °C, see Table 1, RBF de-
creased by more than 50%. Since MAP showed little
change, the reduction in RBF was brought about by a
more than twofold increase in renal vascular resistance
(RVR). In the second hypothermic period (period 3), the
vascular resistance remained essentially unchanged after
intravenous infusion of either the NO precursor L-
arginine or the NO donor SNP. Inhibition of NO syn-
thesis by L-NNA led to a further, marked increase in
RVR. Consequently, RBF decreased from 5.2 ± 1.25 to
1.4 ± 0.38 mL/min (p < 0.001) and GFR from 0.8 ± 0.2
to 0.2 ± 0.05 mL/min (p < 0.001). These changes were
obtained despite of the fact that L-NNA increased MAP
by about 20%. The same pattern was observed in nor-
mothermia (Table 2), where L-arginine and SNP only
evoked modest changes in RVR. After inhibition of
NO synthesis by L-NNA, however, the resistance in-
creased with a concomitant reduction in both RBF and
GFR although MAP increased by 30%.
Series II: autoregulation of RBF before and
during infusion of SNP
Figure 1 depicts the relation between MAP and RBF
blood flow from an experiment in one specimen during
NT and HT at 28 °C, before and during intrarenal infu-
sion of SNP. Figure 2 summarises data from all auto-
regulation curves obtained, and effects of HT on renal
function before and after intrarenal infusion of SNP are
summarised in Table 3. Autoregulation curves in Fig. 2a
were constructed so that the values falling on the as-
cending portion of the curves were fitted to one line
and those within the autoregulatory range to a second,
horizontal line. The lower end of the autoregulatory
range was defined as the point of intersection between
these two lines. The kidney was able to autoregulate the
blood flow under normal temperature and hypothermic
conditions. The main difference seen was that RBF de-
creased from 7.6 ± 0.3 mL/min under NT to
3.9 ± 0.3 mL/min during HT. In Fig. 2b, the perfusion
pressure was set against RVR. During HT, the vascular
resistance at perfusion pressures below the lower point
of inflexion was substantially elevated as compared to
NT. This increase in resistance was partially released
Table 1 The effects of L-
arginine, SNP and L-NNA given
intravenously before and during
period 3, on renal function during
HT
Parameter Period 1 NT Period 2 HT Period 3, HT effects of vasoactive
substances
MAP (mmHg) 124 ± 3.3 120 ± 4.9 after L-ARG 116 ± 5.6
122 ± 2.3 121 ± 3.4 after SNP 98 ± 0.7**ooo
113 ± 2.9 121 ± 4.4 after L-NNA 148 ± 8.9***ooo
GFR (mL/min) 1.43 ± 0.09 0.54 ± 0.04*** after L-ARG 0.63 ± 0.05***
1.49 ± 0.05 0.71 ± 0.06*** after SNP 0.61 ± 0.04***
1.40 ± 0.24 0.82 ± 0.22** after L-NNA 0.22 ± 0.05***ooo
RBF (mL/min) 10.5 ± 1.5 3.7 ± 0.2*** after L-ARG 4.4 ± 0.5***
8.9 ± 0.7 4.0 ± 0.6*** after SNP 3.1 ± 0.3***
10.2 ± 1.2 5.2 ± 1.2*** after L-NNA 1.4 ± 0.4***ooo
Urine flow (μL/min) 2.3 ± 0.6 5.3 ± 1.2 after L-ARG 7.3 ± 3.0**
2.1 ± 0.4 3.5 ± 0.9 after SNP 1.5 ± 0.4
1.7 ± 0.3 6.7 ± 3.0** after L-NNA 2.0 ± 0.6°
UNaV (μmol/min) 0.13 ± 0.06 0.36 ± 0.18 after L-ARG 0.64 ± 0.37*
0.09 ± 0.02 0.21 ± 0.07 after SNP 0.09 ± 0.05
0.08 ± 0.01 0.52 ± 0.24** after L-NNA 0.19 ± 0.10o
Vascular resistance (mmHg min/mL) 10.9 ± 1.7 29.7 ± 2.0** after L-ARG 24.1 ± 1.6
12.6 ± 0.9 27.8 ± 5.1*** after SNP 28.4 ± 2.6
10.1 ± 1.2 21.3 ± 5.0** after L-NNA 98.5 ± 11.0**oo
Values are shown asmean ± SE. n = 5 in the L-ARG group, n = 6 in the SNP group and n = 6 in the L-NNA group.
The closing pressure (10 mmHg) has been subtracted when calculating vascular resistance
MAPmean arterial blood pressure, GFR glomerular filtration rate, L-ARG L-arginine, SNP sodium nitroprusside,
RBF renal blood flow, UNaV renal sodium excretion
*p < 0.05, **p < 0.01, ***p < 0.001, versus period 1; °p < 0.05, oo p < 0.01, ooo p < 0.001 versus period 2
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when SNP was infused via the renal artery (dashed
l ine) . At b lood pressures in the range where
autoregulatory activity occurred during HT, the slope
was less steep during SNP infusion than under condi-
tions without the NO donor. During NT, no difference
in slope was expected since both autoregulatory curves
(w/wo SNP) overlapped at NT (see Fig. 1).
As illustrated in Fig. 3, RBF decreases in proportion
to the body temperature. Since MAP largely remained
unchanged between periods 1 and 2, the reduction in
RBF was due to a rise in RVR.
At the first ascending portion, RBF was found to increase
in proportion to arterial pressure, where each rise in perfusion
pressure, ΔP, was followed by a rise in blood flow, ΔRBF.
The slope of the curve,ΔP/ΔRBF, is in these cases an indirect
estimate of the vascular resistance at any point at the ascend-
ing limb as supported by the findings depicted in Fig. 1. It
should be noted that all the four curves crossed the x-axis at a
Table 2 The effects of L-
arginine, SNP and L-NNA given
intravenously before and during
period 3, on renal function under
control conditions at 37.5 °C
Parameter Period 1
NT
Period 2 NT Period 3, NT effects of
vasoactive substances
MAP (mmHg) 116 ± 3.3 116 ± 2.9 after L-ARG 111 ± 3.4
121 ± 3.1 116 ± 2.5** after SNP 97 ± 0.6**ooo
114 ± 4.0 113 ± 3.4 after L-NNA 148 ± 4.1***ooo
GFR (mL/min) 1.40 ± 0.10 1.52 ± 0.11 after L-ARG 1.42 ± 0.10
1.31 ± 0.13 1.48 ± 0.08 after SNP 1.41 ± 0.06
1.53 ± 0.08 1.54 ± 0.06 after L-NNA 1.11 ± 0.11***ooo
RBF (mL/min) 9.1 ± 1.0 9.5 ± 0.7 after L-ARG 10.0 ± 0.9
9.4 ± 0.8 9.7 ± 1.4 after SNP 9.6 ± 1.1
10.8 ± 1.2 11.5 ± 2.0 after L-NNA 5.3 ± 0.5***ooo
Urine flow (μL/min) 1.3 ± 0.2 2.1 ± 0.4* after L-ARG 3.5 ± 0.7*
2.0 ± 0.2 3.0 ± 0.2** after SNP 2.7 ± 0.7
2.2 ± 0.2 2.6 ± 0.3 after L-NNA 7.0 ± 1.9***°°
UNaV (μmol/min) 0.06 ± 0.01 0.13 ± 0.02** after L-ARG 0.28 ± 0.07*
0.12 ± 0.03 0.20 ± 0.05** after SNP 0.23 ± 0.07
0.15 ± 0.03 0.18 ± 0.04 after L-NNA 0.27 ± 0.13
Vascular resistance
(mmHg min/mL)
11.6 ± 0.8 11.2 ± 1.0 after L-ARG 10.1 ± 1.1
11.7 ± 1.2 10.9 ± 2.4 after SNP 9.2 ± 1.3
9.6 ± 0.6 9.0 ± 1.4 after L-NNA 26.0 ± 2.3***ooo
Values are shown asmean ± SE. n = 6 in the L-ARG group, n = 4 in the SNP group and n = 5 in the L-NNA group.
The closing pressure (10 mmHg) has been subtracted when calculating the vascular resistance
MAPmean arterial blood pressure, GFR glomerular filtration rate, L-ARG L-arginine, SNP sodium nitroprusside,
RBF renal blood flow, UNaV renal sodium excretion
*p < 0.05, **p < 0.01, ***p < 0.001 versus period 1; °°p < 0.01, ooo p < 0.001 versus period 2
Table 3 The effect of HT on
renal function during control
conditions and at 28 °C, before
and during intrarenal infusion of
SNP
Parameter Period 1 NT Period 2 HT Period 3, HT intrarenal infusion of SNP
MAP (mmHg) 116 ± 3.3 114 ± 2.7 89 ± 1.6***°°°
GFR (mL/min) L 1.28 ± 0.15 0.76 ± 0.18** 0.58 ± 0.06***
R 1.40 ± 0.16 0.62 ± 0.08*** 0.58 ± 0.06***
RBF (ml/min) L 7.6 ± 0.3 3.9 ± 0.3*** 4.0 ± 0.3***
Urine flow (μL/min) L 2.0 ± 0.3 5.2 ± 0.8** 6.9 ± 0.9***°
R 1.6 ± 0.3 4.7 ± 0.6** 4.0 ± 0.9*
UNaV (μmol/min) L 0.09 ± 0.02 0.13 ± 0.05 0.45 ± 0.14*°°°
Values are shown as mean ± SE. n = 8/group
SNP = sodium nitroprusside, MAP mean arterial blood pressure, GFR glomerular filtration rate, L left kidney, R
right kidney, RBF renal blood flow, UNaV renal sodium excretion
*p < 0.05, **p < 0.01, ***p < 0.001 versus period 1; °p < 0.05, ooo p < 0.001 versus period 2
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Bcritical closing pressure^ of about 10 mmHg. This was also
taken into account for in the sense that the renal perfusion
pressure was calculated by subtracting 10 mmHg from
MAP. In practice, the vascular resistances were calculated by
dividing the renal perfusion pressure by the blood flow at the
lower limit of the autoregulatory range.
During normothermia, the Bpassive^ vascular resistance
calculated from the lower end of the autoregulatory range
(or from the slope of the ascending portion) was
10.8 ± 0.58 mmHg min mL−1. At normal blood pressure, the
corresponding resistance was13.4 ± 0.89 mmHg min mL−1.
The increase in resistance brought about by the autoregulatory
vasoconstriction was thus 13.4–10.8 = 2.6 mmHg min mL−1
(p < 0.01).
During infusion of SNP (Fig. 1), neither the slope of the
ascending part of the curve, nor the critical closing pressure
changed. This indicated that the vascular bed was Bpassive^.
Whether or not SNP affected the blood flow within the
autoregulatory range is not known, asMAP decreased to pres-
sures below the autoregulatory limit.
During hypothermia, the Bpassive^ vascular resistance es-
timated from the lower end of the autoregulatory range (or
f r o m t h e s l o p e ) w a s e s t i m a t e d t o
16.5 ± 1.35 mmHg min mL−1. At normal MAP, RVR in-
creased to 24.0 ± 2.29 mmHgmin mL−1. The rise in resistance
offered by the autoregulatory mechanism was thus 24.0–
16.5 = 7.5 mmHg min mL−1, a figure three times higher than
during normal conditions.
After SNP, the resistance obtained from the lower end of
the autoregulatory range decreased from 16.5 to
13.4 mmHg min mL−1 (p < 0.01). The latter figure was con-
sidered to reflect the true Bpassive^ resistance of the renal
vascular bed during HT (Figs. 1 and 2). The blood flow was
not altered within the autoregulatory range by donation of NO.
The approximate twofold increase in resistance, or actually
50% decrease in oxygen delivery during HT at 28 °C, indi-
cates that RBF is determined by the renal metabolic rate,
which is half the normal at these temperatures [4]. In one
experiment, RBF data was obtained during the cooling phase,
suggesting such linear relationship (Fig. 3). Data on urine flow
and sodium excretion obtained during NT and HT, before and
after infusion of vasoactive compounds, are shown in Fig. 4a–
d. In brief, HTwas associated with increased urine production
and sodium output comparedwith NT, which were restored by
SNP infusion. Inhibition of NO synthase with L-NNA had no
significant effect during HT, whereas NO inhibition signifi-
cantly increased urine flow during NT. Although there were
no profound effects of HT on blood pressure, averaged MAP
was significantly (p = 0.005) higher during period 2 with HT
(121.0 ± 0.3 mmHg; n = 17) compared with the same period
with NT (115.0 ± 1.0; n = 15). Stimulation of NO production
with SNP reduced blood pressure and inhibition of NO syn-
thesis with L-NNA increased blood pressure in both groups,
abolishing the differences inMAP betweenNTand HT. Taken
together, this suggests that HT is associated with abnormal
NO bioavailability.
Series III: NO homeostasis and oxidative stress
Plasma levels of cGMP were reduced (Fig. 5a), and the uri-
nary excretion rate of nitrate and nitrite anions (NOx) was
increased during HT (Fig. 5b), indicating reduced NO signal-
ling. However, systemic NOx levels were not different be-
tween the groups during the different periods (NT period 1,
22.26 ± 4.6; NT period 2 31.51 ± 5.4; NT period 1,
28.18 ± 5.3; HT period 2 27.64 ± 2.9; n = 5/group). To further
investigate the regulation of NO markers in the kidney, we
analysed nitrate and nitrite levels in the kidney. Increased me-
tabolism of NO would be associated with accumulation of the
stable nitrate anion whereas levels of the more short-lived
nitrite anion should decrease. Indeed, the renal nitrate concen-
tration (Fig. 5c) was significantly increased whereas nitrite
content (Fig. 5d) tended to be decreased after HT compared
with NT. Although not statistically significant, the nitrate-to-
nitrite ratio was also increased in HT kidneys compared with
NT kidneys (68 ± 6 vs. 39 ± 12, p = 0.08, n = 5/group).
Reduced NO bioavailability in the kidney could be linked to
decreased production or increased metabolism via its interac-
tion with reactive oxygen species. NADPH oxidase is a major
source of superoxide generation in the kidney; however, its
activity was not changed by HT (Fig. 5e–f).
Discussion
In agreement with our previous studies [5, 6] and findings
from other laboratories [4, 11, 16, 33, 39], HT was found to

























Fig. 3 Representative presentation of the relation between body
temperature and RBF in one of the experiments during HT.




















































































































Fig. 4 Summarised data on urine
flow (a, b) and sodium excretion
(c, d) during NT (period 1)
followed by a second period with
either NT or HT (28 °C). During
period 2, the effects of intrarenal
infusion of L-arginine, sodium
nitroprusside, and L-NNA are
shown. *p < 0.05. Values are




Fig. 5 Effects of hypothermia on
NO homeostasis and oxidative
stress. Plasma cGMP (a) and
nitrate + nitrite (NOx) excretion
(b) in rats during two consecutive
periods with normothermia (NT)
or in rats where first period of NT
was followed by hypothermia
(HT). Renal concentrations of
nitrate (c) and nitrite (d) in rats
exposed to NT followed by NTor
NT followed by HT. Traces (e)
and grouped data (f) of renal
NADPH oxidase-derived
superoxide production in rats
exposed to NT followed by NTor
NT followed by HT. *p < 0.05.
Values are shown as mean ± SE.
n = 5/group
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under normal conditions. Since MAP remained largely un-
changed, the depression of the blood flow resulted from a
twofold increase in renal vascular resistance.
In the search for the factor(s) underlying the cold-induced
vasoconstriction, the first series of experiments in the present
study were designed to investigate whether the increased tone
was dependent on a cold-induced inhibition of NO, which in
recent years has been proved to be one of the main determi-
nants of vascular tone [15, 27, 29, 32]. Stimulation of the
synthesis of NO by administration of its precursor L-
arginine or a NO donor as SNP has generally been found to
increase RBF, although not GFR [22, 23, 29]. Conversely,
blocking NO by NO synthase inhibitors has been found to
decrease RBF and GFR despite of the fact that MAP
increases.
In the present study, intravenous infusion of the NO pre-
cursor L-arginine during both normo- and HT did not signif-
icantly affect RBF or GFR. Administration of the NO donor
SNP was more effective in the sense that it reduced MAP
during both these conditions. During HT, SNP was also able
to decrease vascular resistance, however. The failure of L-
arginine to affect renal vessels was to be expected, i.e. since
it seems unlikely that cold should deplete the stores of this
precursor, and the effect of reduced metabolism would seem
more likely. However, higher viscosity due to haemo-
concentration and physical properties may promote increased
shear stress at the endothelial wall and may be expected to
enhance the formation of NO [15, 29]. Still, NO would seem
important since inhibition of NO synthesis by L-NNA in-
creased RVR five-fold in addition to the twofold increase
caused by the HT itself.
From the present second series on the pressure-blood flow
relationship, it was evident that the autoregulatory mechanism
remained functional during HT. This has previously only been
described in the dog [11]. It seems that the setting of the
autoregulatory mechanism is temperature dependent such as
to adjust the blood flow according to the metabolic rate. The
Bsetting^mechanism seems powerful since intrarenal infusion
of an effective NO donor like SNPwas unable to affect RBF at
pressures within the autoregulatory range, only below this
range.
At the first ascending portion of the pressure-flow relation-
ship, the blood flow was linearly related to perfusion pressure
up to the lower limit of the autoregulatory range. The fact that
vascular resistance remained unchanged across the whole of
the ascending portion of the pressure-flow relationship sug-
gests a Bpassive^ vasculature with unchanged vessel diame-
ter(s). At very low perfusion pressure, autoregulation is
discontinued, most likely since the vessels are fully dilated.
However, it will not exclude changes in the vasculature in
question. Within the autoregulatory range, the blood flow
was found to remain remarkably constant with a standard error
of as little as 0.3 mL/min, a constancy obviously due to the
autoregulatory vasoconstriction. We may thus express the
autoregulatory capacity as the rise in resistance when effective
perfusion pressure increases from the lower end of the
autoregulatory range up to normal pressure.
All the autoregulation curves crossed the x-axis at
10 mmHg (Figs. 1 and 2a), thus regarded as the closing pres-
sure. In the interpretation of this phenomenon, it should be
emphasised that the curves were perfectly linear with no sign
of splay in the region close to the crossing with the x-axis. As
previously shown under NT [20], the pressure in the small
intrarenal veins is constantly about 10 mmHg higher than in
extrarenal veins probably due to collapse of the distal part of
the intrarenal veins creating an Boutflow resistance^. For very
low perfusion pressures up to 10 mmHg, all of the intrarenal
veins may be expected to be collapsed. In agreement with this
view, a rise in the central venous pressure above 10 mmHg
eliminates the pressure drop. The physiological significance
of the distinct pressure drop is not known, but it may act to
stabilise the peritubular capillary pressure at 10–13 mmHg,
and hence one of the Starling forces which governs peritubular
capillary fluid uptake. Therefore, it is reasonable to subtract
the critical closing pressure of 10 mmHg from the MAP.
Using this definition, each rise in perfusion pressure,ΔP, any-
where at the ascending portion of the curves is followed by a
correlating increase in RBF,ΔRBF. This feature is typical for
a Bpassive^ vasculature with unchanged diameters; it does not,
however, exclude a change in the size of the vessels. The slope
of the ascending portion will equalΔP/ΔRBF, which thus is a
measure of the vascular resistance. Within the autoregulatory
range (plateau), on the other hand, the blood flow was found
to remain virtually constant.
Under normothermic conditions, the total vascular resis-
tance almost doubled along the plateau. Regarding the first
ascending portion of the pressure-flow relationships, consid-
ered to reflect a Bpassive^ behaviour of the vasculature, the
resistance was estimated to 10.8 mmHg min mL−1 at NT.
After cooling, RVR increased to 16.5 mmHg min mL−1. HT
thus increased Bpassive^ resistance by 5.7 mmHg min mL−1.
Regarding the autoregulatory response, the rise in resis-
tance when passing from the lower end of this range to normal
pressures was found to be 2.6 mmHg min mL−1 during NT
increasing to 7.5 mmHg min mL−1 during HT (i.e. difference
of 4.9 mmHg min mL−1) . HT thus enhanced the
autoregulatory response leading to vasoconstriction, which
may explain the reduction in RBF and GFR during moderate
HT. The resetting of TGF seems plausible as supported by
earlier data from our department [5] where single nephron
GFR measurements show a 50% reduction (approximately)
in both proximal and distal tubular fluid flow during HTcom-
pared to NT. Fractional fluid reabsorption was in fact unaf-
fected by HT, and the increased diuresis during HT could be
attributed the distal tubule and collecting duct as shown in a
previous study [7], in which Arg-vasopressin (AVP) secretion
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was found to decrease with a concomitant increase in water
loss, and a bolus of AVP abolished the cold-induced diuresis.
The NO pathways may well be involved also in these water
handling mechanisms; Ota et al. [30] demonstrated that NO-
mediated signalling in the central nervous system increase the
secretion of ADH, and vice versa. Although neural NO bio-
availability was not assessed in the current investigation, we
found that systemic level of cGMP was reduced by almost
50% during HT, clearly suggesting reduced NO signalling.
Concerning renal metabolic pathways for NO, a decrease in
NO production during HTwas supported by increased urinary
excretion of the NO metabolites nitrate and nitrite (i.e. NOx).
In the kidney, enzymatic reduction of nitrite to NO is associ-
ated with preglomerular vasodilatation and reduction of
NADPH oxidase-mediated oxidative stress. Here, we show
that renal nitrite content decreased whereas nitrate increased
(Fig. 5c–d), suggesting increased oxidation of NO. Although
some previous studies have suggested HT-mediated modula-
tion of oxidative stress in models of ischemia or hypoxia [34,
35], the observed reduction of NO bioavailability in the cur-
rent study cannot be explained by increased NADPH oxidase
activity (Fig. 5b).
Regarding the site of the cold-induced vasoconstriction, the
Bpassive^ resistance will probably affect both pre- and
postglomerular vessels, each of them contributing with
2.85 mmHg min mL−1. This is partly due to increased viscos-
ity from temperature per se, and a slight physiological increase
in haematocr i t [3 , 5] . The act ive component of
4.9 mmHg min mL−1 will only affect preglomerular resis-
tance, i.e. since it is generally agreed that renal autoregulation
is the result of changes in these vessels [20, 29]. Thus, to the
total cold-induced rise in renal vascular resistance of
10.6 mmHgmin mL−1, the preglomerular vessels will contrib-
ute with 70% (7.75 mmHg min mL−1) and the postglomerular
with 30% (2.85 mmHg min mL−1).
It should be noted that if the pre- and postglomerular in-
crease in resistance was the same, the glomerular capillary
pressure would be expected to remain unaltered. If the largest
part occurs at the preglomerular vessel segments, however, the
glomerular capillary pressure would decrease. The latter is
also in accordance with the data of Broman and Källskog
1995 [5] reporting a fall in the glomerular capillary pressure
from 56.7 ± 0.6 mmHg during NT to 46.5 ± 1.3 mmHg during
HT. The authors also calculated the contributions of the pre-
and postglomerular resistances showing that 70% of the HT
induced increase in resistance was due to preglomerular ves-
sels, i.e. the same fractions obtained from the present data.
During NT, intra-arterial infusion of SNP did not affect the
ascending portion of the curves. The data produced the same line
as during normal conditions. Since SNP also decreasedMAP, the
effect of SNP within the autoregulatory range is not known.
During HT (Fig. 2b), during SNP infusion, the Bpassive^
resistance at the ascending portion of the curves showed an
increase to 13.3 mmHg min mL−1. This is in fact the same as
duringNTconsidering that the blood viscosity at 28 °C is 25%
higher than at 37.5 °C [3, 12]. Evidently, SNP was able to
unmask the true Bpassive^ resistance during HT, the differ-
ence between the data before and after SNP was
3.1mmHgminmL−1. SNP had no effect on the autoregulatory
vasoconstriction. As seen in Fig. 2b, still during HT, the slope
of the active part of the autoregulation curve is more steep
before SNP infusion then after, indicating less active vascula-
ture since the autoregulation in the latter case also is acting
accordingly but from a lower perfusion pressure, with the
default goal—to maintain renal perfusion flow according to
metabolic demand. Thus, the present investigation revealed
that the autoregulatory vasoconstriction was able to override
the vasodilatory action of NO. This may also explain the fail-
ure of intravenous infusion of SNP to alter RBF investigated
in our first series of studies. In contrast, blockade of the NO
synthesis by L-NNA was able to further decrease the blood
flow also within the autoregulation range.
The present study specifically investigating the role of the NO
pathway does not solve all the questions concerning the under-
lying mechanism(s) contributing to the resetting of the renal
autoregulation during HT. However, our findings add to current
understanding in the sense that the setting of this mechanism is
dependent on the metabolic rate as shown in Fig. 3. Although a
modulatory role should not be excluded, it is clear that the setting
is not mediated via NO since administration of SNP or L-
arginine did not significantly change the autoregulatory plateau.
The latter findingmay also be of clinical significance in the sense
that administration of, e.g. SNP to lessen the work load of the
heart can be expected not to compromise RBF. Furthermore,
since the NO donor shifted the autoregulatory plateau to the left
by 10–15 mmHg, the RBF will remain unaffected even if MAP
would decrease with 10–15 mmHg. It is concluded that the
twofold increase in renal vascular tone seen during HT at
28 °C ismainly due to a temperature-dependent resetting of renal
autoregulation, which cannot be explained by a reduction of
endogenous synthesis of NO alone.
Our group had earlier mapped the resistance pattern along
the renal microcirculation during hypothermia [5]. The results
showed that the dominating part of the increase in RVR could
be addressed to the preglomerular vessels. At hypothermia,
renal sympathetic tone was substantially decreased, promot-
ing reduced vascular tone, and increase in sodium and water
excretion [6]. It has been proposed by Ito and Abe 1997 [19],
and may be argued, that under normal circumstances the
mechanisms regulating afferent and efferent vascular tone
are different. On the afferent side, the myogenic response
and the TGF mechanisms dominate in maintaining GFR,
NO being the main modulator. Prostaglandins (PG) would
be more important for efferent arteriole, but NO and AngII
are also important. Concerning PGs, an increase in renal PG
synthesis would promote natriuresis by inhibiting sodium and
Pflugers Arch - Eur J Physiol
water reabsorption. It has been shown, at least in mice, that
there is a parallel water handling system via PGE2 and the
EP4 receptor. A downregulation of aquaporin 2 by less PGE2
receptor EP4 stimulation leads to water dieresis [26]. The
vasopressin system, however, works in parallel and was nei-
ther down- or upregulated in EP4 knock-out mice compared to
wild type; both genetic types increased urine concentration to
the same extent after an injection of desmopressin (dDAVP).
In the series of studies from our department [5–7], the cold-
induced diuresis was found to be due to a decrease in AVP
excretion, and a single dose of dDAVP completely reversed
the cold-induced diuresis [7]. This strongly suggests PGs not
to be contributing to the tubular changes in water handling
during moderate hypothermia. Thus, in the light of the current
results concerning the NO system, it is less likely that the renal
blood flow alterations during hypothermia are PG-dependent.
A limitation of the present study is that a pharmacological
approach was used to target NO signalling, and it is difficult to
know the effectiveness of the doses used (e.g. sufficient
amount reaching the vascular smooth muscle). Although tech-
nically more challenging future studies could benefit from
using a genetic approach (e.g. targeting eNOS signalling),
other potential candidates, apart from NO that would be of
interest for future hemodynamic investigation since they are
known to modulate renal autoregulation [10], include signal-
ling by prostaniods (prostaglandin, thromboxane and prosta-
cyclin), and possibly altered signalling by endothelium-
derived hyperpolarizing factor [13].
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